PARSIPPANY, N.J. and INDIANAPOLIS, Oral antiplatelet therapy Effient® (prasugrel) has been added to the updated clinical practice guidelines as a Class I recommended treatment option for patients ...

The American College of Cardiology and American Heart Association (ACC/AHA) have issued new guidelines for the revascularization of coronary artery disease. The recommendations, which were drafted in ...

The American College of Cardiology Foundation has recently released revised guidelines for coronary artery bypass graft surgery and percutaneous coronary intervention, according to ACC news releases.

Dennis T. Ko, M.D. However, a significant proportion of STEMI patients will "fail" to reperfuse following fibrinolytic therapy; indeed, normal coronary blood flow (TIMI flow grade 3) is achieved in ...

Dual antiplatelet therapy with a thienopyridine in combination with aspirin for 1 to 6 months after stenting has been recommended by the manufacturers to reduce ischemic cardiovascular events and ...

The American College of Cardiology and the American Heart Association today released an updated clinical practice guideline for managing individuals experiencing acute coronary syndrome (ACS). The ...

"The new guidelines issued by the ACCF and AHA recognize Effient as an important treatment option for the population of ACS patients who receive PCI with or without a stent after experiencing unstable ...